Capricor Therapeutics (CAPR) Misses Q2 EPS by 2c

August 15, 2016 4:45 PM EDT
Get Alerts CAPR Hot Sheet
Trade CAPR Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Capricor Therapeutics (NASDAQ: CAPR) reported Q2 EPS of ($0.26), $0.02 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Capricor Therapeutics (CAPR) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment